 |
|
gusperimus
A derivative of the antitumor antibiotic spergualin with immunosuppressant activity. Gusperimus inhibits the interleukin-2-stimulated maturation of T cells to the S and G2/M phases and the polarization of the T cells into IFN-gamma-secreting Th1 effector T cells, resulting in the inhibition of growth of activated naive CD4 T cells; this agent may suppress growth of certain T-cell leukemia cell lines. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | deoxyspergualin
Deoxyspergualin Hydrochloride
Gusperimus Trihydrochloride | | | | Foreign brand name: | | Spanidin | | | | Abbreviation: | | DSG | | | | Code names: | | BMS-181173
BMY-42215-1
NKT-01 | | | | Chemical structure names: | | - 15-deoxyspergualin hydrochloride
- 1-amino-19-guanidino-11-hydroxy-4,9,12-triazanonadecane-10,13-dione
- 7-{(aminoiminomethyl)amino]-N-[2-[[4-[(3-aminopropyl)amino]butyl]amnio]-1-hydroxy-2-oxoethyl]heptanamide
- N-[[[4-[(3-Aminopropyl)amino]-butyl]carbamoyl]hydroxymethyl]-7-guanidinoheptanamide
| | |
|
|
